Skip to content
healthcare.dev

Tizanidine

NDC 67877-613, Tizanidine, tablet, from Ascend Laboratories, LLC.

Product NDC
67877-613
Status
Listed
Labeler
Ascend Laboratories, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211798
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67877-613 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIZANIDINE HYDROCHLORIDE2 mg/1

Pharmacologic classes

Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
67877-613-0567877061305500 TABLET in 1 BOTTLE (67877-613-05)
67877-613-1567877061315150 TABLET in 1 BOTTLE (67877-613-15)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/72f25135-1333-4e52-83f5-7df7d90e68bb
  • NADAC price for package 67877061315

    GET /v1/drugs/nadac/67877061315

Use it

Look up 67877-613 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67877-613 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67877-613. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.